| | | Partners |  |  | Pharma in Focus • Feb 12, 2021 23:1 |  | | The blockbuster Novartis CAR-T therapy Kymriah will be commercially produced in Australia for the first time after the TGA gave the ... Cell Therapies to commence manufacturing at its facility at the Peter MacCallum Cancer Centre in Melbourne. Hailed as a win for Australians |
|
| | SBS (Licensed by Copyright Agency) • Feb 12, 2021 19:11 | | | A state-of-the-art facility in Melbourne is to join just a handful of sites globally permitted to produce the CAR- ... the CAR-T cell therapy. Production of the therapy is to begin at the Cell Therapies facility within the Peter MacCallum Cancer Centre (SBS) |
|
| | Aboutpain - Newswire • Feb 12, 2021 15:31 | | | Sydney, Feb. 12, 2021 /Medianet ... to Kymriah for patients • Cell Therapies located within the Peter MacCallum Cancer Centre, Melbourne, has become the first approved |
|
| | Australian Manufacturing • Feb 12, 2021 13:43 | | | Image Credit: Peter MacCallum Cancer Centre With TGA approval in check, Melbourne will house Australia’s first and only ... Image Credit: Peter MacCallum Cancer Centre With TGA approval in check, Melbourne will house Australia’s first and only |
|
| | Aboutpain - Newswire • Feb 12, 2021 13:33 | | | Sydney, Feb. 11, 2021 /Medianet/ -- Dr Shelley Dolan, Chief Executive, Peter MacCallum Cancer Centre A/Prof Dominic Wall, Executive ... at Peter Mac Dr Michael Dickinson, Haematologist at Peter Mac Patient Angie, who received CAR-T therapy Kymriah at the Peter Mac |
|
| | Aboutpain - Newswire • Feb 12, 2021 13:30 | | | Sydney, Feb. 12, 2021 /Medianet/ -- TGA approves first Australian commercial CAR-T manufacturing site Novartis and Cell Therapies Pty Ltd ... on the local manufacturing of CAR-T therapy in Australia, within a manufacturing facility at the Peter MacCallum Cancer Centre, Melbourne. |
|
| | Gold Coast Bulletin (Licensed by Copyright Agency) • Feb 12, 2021 7:2 | | | One of the world’s most groundbreaking medicines will be produced in Melbourne after the remarkable success of ... -engineering technology in saving Australian cancer patients. From today the Peter MacCallum Cancer Centre will become Asia Pacific’s key |
|
|
| | | Grants | | | Mirage News • Feb 10, 2021 9:21 | | | The Morrison Government is investing $8 million to support the Children’s Tumour Foundation and research into neurofibromatosis, a ... children who live with neurofibromatosis. The MRFF is a long-term, sustainable investment in Australian health and medical research helping |
|
|
| | | Blood Cancers | | | Herald Sun (Licensed by Copyright Agency) • Feb 12, 2021 6:0 | | | Melbourne will become one of only a few cities in the world to manufacture one of the world’s most groundbreaking ... will be produced in Melbourne after the remarkable success of genetic-engineering technology in saving Australian cancer patients. From |
|
| | Oncology News Australia • Feb 11, 2021 8:10 | | | A first-of-its-kind Australian study has revealed rates of brain lymphoma have quadrupled since the 1980s with only 33% of people surviving ... As the human eye is connected to the brain, the lymphoma can also start in the eye (retinal lymphoma) and later spread to the brain. First |
|
| | Financial Review (Licensed by Copyright Agency) • Feb 8, 2021 11:43 | | | Save Log in or Subscribe to save article Share One night in 2019 Jemma Katz scratched her neck and felt a lump. ... , I’m talking about lives,” he said. Ms Katz, whose Hodgkin’s lymphoma cancer has been in remission since last year, said it was easy to |
|
|
| | | Head and Neck | | | PH News Hub • Feb 9, 2021 13:59 | | | Living longer, recovering faster, and facing less likelihood of readmission – cancer patients at Chris O’Brien Lifehouse receive better ... Lifehouse have a much higher chance of surviving ovarian, head and neck, lung and neurological cancer, and sarcoma than the state average. “ |
|
|
| | | Lung Cancer | | | Oncology News Australia • Feb 11, 2021 8:10 | | | Adding ipilimumab to pembrolizumab does not improve efficacy and is associated with greater toxicity than pembrolizumab alone as first-line ... and the Central Clinical School of the University of Sydney, Sydney, Australia. Previously, the KEYNOTE-024 study showed that pembrolizumab |
|
|
| | | Melanoma | | | Port Macquarie News (Licensed by Copyright Agency) • Feb 11, 2021 12:0 | | | Ryan Channells was staring down flames in last year's Black Summer bushfires when he was also fighting another ... to their lymph nodes,' said Professor Georgina Long AO, Melanoma Institute Australia (MIA) Co-Medical Director and study senior author. "We |
|
| | Your Life Choices • Feb 9, 2021 13:23 | | | Australian doctors report a major breakthrough using immunotherapy. . Australia has the highest melanoma rates in the world, with one person diagnosed every 30 minutes, and the Melanoma Institute Australia, |
|
|
| | | Pancreatic Cancer | | | Oncology News Australia • Feb 11, 2021 8:10 | | | UNSW scientists have grown human pancreatic cancer tumours in the lab—their model is the first of its kind, with important future clinical ... Cancer Australia and the Department of Health are leading. She is also the co-lead of UNSW’s Pancreatic Cancer Research Hub, Australia’s |
|
|
| | | Sarcoma | | | PH News Hub • Feb 9, 2021 13:59 | | | Living longer, recovering faster, and facing less likelihood of readmission – cancer patients at Chris O’Brien Lifehouse receive better ... they are unwilling to expose themselves to the risk of infection. “Cancer Australia data has shown that there has been a drop in screening, |
|
|
| | | Men's Cancer | | | Share Cafe • Feb 11, 2021 23:30 | | | February 11, 2021 11, 2021 By Staff Writers | More Articles by Staff Writers Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug |
|
| | Health Industry Hub • Feb 10, 2021 7:39 | | | Pharma News: Australian clinical-stage drug development company Noxopharm reported on the publication in abstract form of the latest ... in an independent study and is being shared on the world stage by leading Australian researchers. The reported median overall survival (OS) |
|
| | ARN • Feb 9, 2021 18:14 | | | The global Castrate-resistant Prostate Cancer market size is expected to be worth around US$ 16.4 billion by 2028, according to a new ... Spain Russia Asia Pacific Japan China India South Korea Singapore Australia Latin America Brazil Mexico Argentina Middle East & Africa |
|
| | The Border Mail (Licensed by Copyright Agency) • Feb 9, 2021 17:0 | | | Having access to information empowers cancer patients to make sound and well informed choices, says the North East ... cancer, which is one of the most common cancers for males with 45 Australian men diagnosed a day. One in every six men will be diagnosed |
|
| | The North West Star (Licensed by Copyright Agency) • Feb 8, 2021 14:23 | | | Motorsport great John Bowe has announced he has been diagnosed with prostate cancer. The 66-year-old from ... from Devonport, the multiple Bathurst and Australian Drivers Championship winner and Australian Touring Car Championship winner, announced |
|
| | NZ City • Feb 8, 2021 12:7 | | | Australian motorsport icon John Bowe has revealed he's been diagnosed with prostate cancer The two-time Bathurst 1000 winner, who also won the 1995 Australian Touring Car Championship has announced he will begin treatment this week |
|
| | V8SLEUTH • Feb 8, 2021 10:14 | | | JOHN Bowe has revealed that he has been diagnosed with prostate cancer. treatment on Tuesday at the new Peter McCallum Cancer Clinic in North Melbourne. After that I’m not sure because there are several options.” |
|
|
| | | Women's Cancer | | | Prevention • Feb 11, 2021 23:59 | | | Mandy Wales, 42, discusses the resilience and purpose she's found during her battle with breast cancer. 3C cancer and I had to have chemotherapy first to shrink the tumour. Because my cancer was so aggressive, the normal treatment cycle, where |
|
| | Perth Now (Licensed by Copyright Agency) • Feb 11, 2021 12:50 | | | Conquering breast cancer has reignited a childhood passion for fashion for South Perth resident Karen Young. Ms ... teaching. “I taught primary school for 27 years but in 1993 I entered an Australian design competition I saw in Woman’s Day,” she said. “My |
|
| | The Latch • Feb 11, 2021 12:31 | | | Ovarian cancer is often called “the silent killer”. Unlike other female cancers, there is no method for early detection — symptoms are ... swabs to determine whether or not the same proteins are present in ovarian cancer tumour tissues.” What they ended up finding in the Pap |
|
| | COSMOS Magazine • Feb 9, 2021 15:31 | | | Research groups find increased prevalence and suggest earlier screening. ). While breast cancer cases remain highest in westernised countries, with Australia, Europe and the US topping the list, death rates are 17 |
|
| | Science Media Exchange - Scimex • Feb 9, 2021 9:21 | | | A mammography screening strategy based on a baseline breast density measure at age 40 may be the most effective and cost-effective way to ... to reduce deaths from breast cancer, according to a US computer modelling study. Currently, women are screened from age 50 in Australia. The |
|
|
| | | Treatment Development | | | Redland City Bulletin (Licensed by Copyright Agency) • Feb 14, 2021 8:25 | | | "I took the chance ... it was better than dying." melanoma which had spread to his lymph nodes. In a groundbreaking new approach which flipped the "surgery then drugs" order of treatment |
|
| | Ntnews.com.au (Licensed by Copyright Agency) • Feb 11, 2021 16:11 | | | Researchers have developed a new test they hope will be 'a game changer’ for esophageal cancer patients. Professor ... ”. QIMR Berghofer has notified the Australian Cyber Security Centre and the Office of the Australian Information Commissioner. Anyone with |
|
| | The Sydney Morning Herald (Licensed by Copyright Agency) • Feb 10, 2021 23:25 | | | Australian researchers have found chronic kidney disease, cancer, diabetes, and hypertension are the four main ... Australian researchers have found chronic kidney disease, cancer, diabetes, and hypertension are the four main conditions contributing to |
|
| | Health Industry Hub • Feb 10, 2021 7:39 | | | Pharma News: Australian clinical-stage drug development company Noxopharm reported on the publication in abstract form of the latest ... study and is being shared on the world stage by leading Australian researchers. The reported median overall survival (OS) outcome of 19.7 |
|
| | Oncology News Australia • Feb 10, 2021 5:11 | | | Australian researchers and colleagues from Nagoya University, Japan, have revealed that colorectal cancer tissues contain at least two ... Australian researchers and colleagues from Nagoya University, Japan, have revealed that colorectal cancer tissues contain at least two types |
|
|
| | | COVID-19 & Cancer | | | Illawarra Mercury (Licensed by Copyright Agency) • Feb 12, 2021 17:0 | | | Illawarra oncologists and GPs fear that the focus on the COVID-19 pandemic over the past year, has caused many to ... -19 pandemic in Australia in early 2020 forced a temporary closure of some screening services, such as BreastScreen Australia, as healthcare |
|
| | The Sydney Morning Herald (Licensed by Copyright Agency) • Feb 10, 2021 23:25 | | | Australian researchers have found chronic kidney disease, cancer, diabetes, and hypertension are the four main ... Australian researchers have found chronic kidney disease, cancer, diabetes, and hypertension are the four main conditions contributing to |
|
| | Ntnews.com.au (Licensed by Copyright Agency) • Feb 9, 2021 11:44 | | | Samantha Maiden brings your top COVID-19 vaccine concerns to Professor Cheng, an infectious disease specialist, ... broken bones sustained by the Australian population last year. The patient organisation has called for Australians to “prioritise their bone |
|
| | Jimboomba Times (Licensed by Copyright Agency) • Feb 8, 2021 12:23 | | | Oncologists are urging anyone who put off health concerns due to COVID-19 to speak to their GP. The Icon Cancer ... you have to go to Melbourne so the anxiety I think for many patients during the lockdown period about going into Melbourne put off a lot of |
|
|
|
|
|
|
